With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
"Britain's promise to buy vaccines against HIV/AIDS and malaria for distribution in poor countries, which it hopes will provide the financial carrot necessary to get drug firms to develop them, is a potentially excellent use of an aid budget."
The Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) was established very quickly in 2001 in response to a widespread perception that a rapid scale-up in financing was critical in the fight against the three diseases. Since it began operations in January 2002, GFATM has made important progress. It has raised substantial funding and become the world’s largest donor for TB and malaria. 70% of the programs reaching the two-year renewal stage are showing solid results. Rwanda, for example, has put over 4,000 people on ARV treatment, more than double its program target, and GFATM programs in aggregate have financed ARV treatment for 130,000 people to date.
Immunization is one of the safest ways to reduce disease and poverty in developing countries. But 3 million people die every year of vaccine-preventable diseases; and that will likely rise to 4.5 million when rotavirus and pneumococcus vaccines are available, if past experience is any guide. And progress towards vaccines suitable for HIV, malaria and tuberculosis is painfully slow.
In this chapter from Markus Haacker's book on the macroeconomic implications of HIV/AIDS, Nancy Birdsall and Amar Hamoudi discuss the effect AIDS has on the supply of and demand for education in Africa.
Smart generals study history. The lessons of battles past provide valuable clues about how to win in the future. In the war against AIDS in the developing world we need to study how major successes have been achieved in health programs and how to apply those lessons today.